Year: 2014
Type: article
Abstract: The past five years have borne witness to remarkable progress in almost all areas of hepatology, including: improved understanding of the molecular pathophysiology of developmental, infectious, inflammatory, metabolic and neoplastic liver diseases; the introduction of non-invasive diagnostic tools for fibrosis, and the discovery of direct acting anti-viral agents for hepatitis C, among many others [1–10]. These advances have resulted in part from successful efforts to link basic science and clinical research, as reviewed in a special conference on translational research organized by the European Association for the Study of the Liver (EASL) in Lyon, France in November 2013 [11].
Source: Journal of Hepatology
Authors: Daniel Shouval, Scott L. Friedman
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,500
OpenAlex ID: W2012270983
